HCKK Ventures (539224)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹100.66 |
| Market Cap | ₹38.46 Cr |
| P/E Ratio | 84.53 |
| ROCE | 6.93% |
| ROE | 3.2% |
| Dividend Yield | 0% |
| Profit Growth | -140% |
| Debt/Equity | — |
| Sales Growth | -100% |
| 52-Week Range | ₹26.5 — ₹100.66 |
| Sector | Diversified |
| Book Value | ₹12.12 |
Strengths
- Positive book value of ₹12.12 provides a tangible asset baseline.
- ROCE of 6.93% is more than double ROE, suggesting some capital is being employed productively.
- Latest quarter net loss is negligible at ₹0 Cr, so there is no visible cash drain.
- Price is at the 52-week high, indicating strong market interest, though this is not a value signal.
Concerns
- Latest quarter sales are ₹0 Cr with sales growth of -100%, meaning there is no underlying operating revenue.
- P/E of 84.53 is meaningless on near-zero earnings, and profit growth has declined 140%.
- P/B of 8.31 against book value of ₹12.12 means paying 8x book for a 3.20% ROE.
- Piotroski F-Score of 3/9, zero dividend yield, and undisclosed promoter holding signal poor financial transparency and health.
AI Analysis
Looking at HCKK Ventures, I feel like I'm staring at a shell, not a business. The latest quarter has sales of ₹0 Cr and a negligible net loss of ₹0 Cr, yet the market prices this at ₹100.66 per share, a 52-week high, with a market cap of ₹38 Cr. That is extraordinary. A P/E of 84.53 means little when earnings are essentially zero and profit growth has fallen 140%. The balance sheet shows book value of ₹12.12 per share, so the share price is 8.31 times book. For a company earning just 3.20% on equity, paying 8 times book offers no margin of safety whatsoever. Graham would say the price is what you pay, value is what you get; here I see no reliable stream of value. The Piotroski F-Score of 3/9 confirms poor financial health—this is not a company generating cash or improving operations. Sales growth of -100% is a red flag; a business with no revenue cannot be valued on P/E or simple multiples. The only mildly encouraging figures are ROCE of 6.93%, which exceeds ROE, and a positive book value, but with zero sales these are not enough. Promoter holding is undisclosed, debt/equity is not available, and dividend yield is zero. This is not an investment; it is a speculative situation. I need proof of profitable operations, a clear business plan, and evidence that management is creating value for minority shareholders. Until then, I would rather wait for a margin of safety. In the words of Buffett: 'Risk comes from not knowing what you're doing.' Here, the figures tell me I don't know enough, and that is enough to walk away.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer